Home > Compound List > Product Information
Cefotaxime sodium salt_Molecular_structure_CAS_64485-93-4)
Click picture or here to close

Cefotaxime sodium salt

Catalog No. C7912 Name Sigma Aldrich
CAS Number 64485-93-4 Website http://www.sigmaaldrich.com
M. F. C16H16N5NaO7S2 Telephone 1-800-521-8956
M. W. 477.44731 Fax
Purity Email
Storage Chembase ID: 133418

SYNONYMS

Title
Cefotaxime sodium salt 钠盐
IUPAC name
sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
IUPAC Traditional name
sodium cefotaxime(1-)
Synonyms
Cefotaxim sodium salt 钠盐

DATABASE IDS

PubChem SID 24278336
CAS Number 64485-93-4
EC Number 264-915-9
MDL Number MFCD00079073
Beilstein Number 5711411

PROPERTIES

Potency 916-964 μg per mg
Suitability suitable for 1694 per US EPA
GHS Pictograms GHS08
GHS Signal Word Danger
GHS Hazard statements H317-H334
European Hazard Symbols Harmful Harmful (Xn)
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Faceshields, Gloves
GHS Precautionary statements P261-P280-P342 + P311
Risk Statements 42/43
RTECS XI0250000
Safety Statements 22-36/37
Storage Temperature 2-8°C
German water hazard class 2

DETAILS

Description (English)
Biochem/physiol Actions
Used to study the effect of expression, binding and inhibition of penicillin-binding proteins especially PBP2 on bacterial cell wall mucopeptide synthesis.
Cefotaxim inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. As a result, bacteria lyse due to cell wall autolytic enzymes.
Other Notes
Broad spectrum third generation cephalosporin antibiotic.
Application
Cefotaxim is a broad spectrum third generation cephalosporin antibiotic that is used to study the effect of expression, binding and inhibition of penicillin-binding proteins especially PBP2 on bacterial cell wall mucopeptide synthesis. It has been used to find new residues involved in cefotaxime hydrolysis in CTX-M β-lactamases1, to study antibiotic-susceptible and -resistant Streptococcus pneumoniae infections 2, and to study pneumococcal pneumonia and the pharmokinetics of various treatments3.
Protocols & Applications
Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information

REFERENCES